We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Orna Therapeutics Stock

Invest in or calculate the value of your shares in Orna Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Orna Therapeutics Stock (ORNT)

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

About Orna Therapeutics Stock

Founded

2019

Headquarters

Cambridge, MA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.

Orna Therapeutics Management

Leadership team at Orna Therapeutics

Founder & Director, Molecular Biology

Alex Wesselhoeft

Founder, Director of Business Development & Former Board Director

Raffaella Squilloni

Locked Features

Join now and verify your accreditation status to gain access to:

  • Orna Therapeutics current valuation
  • Orna Therapeutics stock price
  • Available deals in Orna Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Orna Therapeutics Stock

How to invest in Orna Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Orna Therapeutics through EquityZen funds. These investments are made available by existing Orna Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Orna Therapeutics stock?

Shareholders can sell their Orna Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."